Related Experiment Video
Updated: Nov 17, 2025

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
Improving Outcomes for Patients With Advanced Urothelial Carcinoma
Petros Grivas1, Jeannette Hammond1
1University of Washington/Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Abstract:
At JADPRO Live 2019, Petros Grivas, MD, PhD, and Jeannette Hammond, PA-C, reviewed data regarding mechanistic activity, efficacy, and safety of approved and emerging therapies for advanced or metastatic urothelial carcinoma, the selection of appropriate lines of therapy, and strategies for managing adverse events.
Insights
This review covers new and approved treatments for advanced urothelial carcinoma, focusing on their effectiveness, safety, and how to manage side effects.
Area of Science:
- Oncology
- Pharmacology
Background:
- Advanced or metastatic urothelial carcinoma presents significant treatment challenges.
- Current therapeutic options require ongoing evaluation for optimal patient outcomes.
Purpose of the Study:
- To review mechanistic activity, efficacy, and safety of approved and emerging therapies for advanced urothelial carcinoma.
- To discuss strategies for selecting appropriate lines of therapy.
- To outline methods for managing adverse events associated with urothelial carcinoma treatments.
Main Methods:
- Review of data presented at JADPRO Live 2019.
- Expert discussion on therapeutic strategies and safety profiles.
Main Results:
- Key data on approved and emerging therapies were analyzed.
- Considerations for treatment sequencing and adverse event management were highlighted.
Conclusions:
- Optimizing treatment selection and supportive care is crucial for patients with advanced urothelial carcinoma.
- Continuous review of therapeutic advancements is necessary to improve patient care and outcomes.
More Related Videos
06:39Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
Published on: November 22, 2019
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Related Concept Videos
Treatment Resistant Cancers
Urinary Tract Infection IV: Nursing Management
Urinary Tract Calculi VI: Surgical Management
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi V: Nursing Management